| Literature DB >> 21576427 |
Thomas Pouplin1, Julie Nguyen Pouplin, Pham Van Toi, Niklas Lindegardh, H Rogier van Doorn, Tran Tinh Hien, Jeremy Farrar, M Estée Török, Tran Thi Hong Chau.
Abstract
The recommended treatment for herpes simplex encephalitis (HSE) remains intravenous acyclovir. In resource-poor countries, however, intravenous formulations are usually unavailable or unaffordable. We report the penetration of acyclovir into the cerebrospinal fluid (CSF) in patients with HSE, treated with the oral prodrug valacyclovir at 1,000 mg three times daily. The oral therapy achieved adequate acyclovir concentrations in the CSF and may be an acceptable early treatment for suspected HSE in resource-limited settings.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21576427 PMCID: PMC3122427 DOI: 10.1128/AAC.01023-10
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191